Literature DB >> 6418635

Complementation analysis in Gaucher disease using single cell microassay techniques. Evidence for a single "Gaucher gene".

R A Gravel, A Leung.   

Abstract

Gaucher disease is a lysosomal storage disorder resulting from a deficiency of acid beta-glucosidase. Several clinical forms have been described, including infantile, juvenile, and adult onset variant. We have examined complementation in infantile and adult forms of Gaucher disease by monitoring enzyme activity in multinucleate cells produced by fusing skin fibroblasts from different patients in the presence of polyethylene glycol. beta-Glucosidase activity was monitored in lysates of individual multinucleate cells by a microassay method utilizing methylumbelliferyl-beta-D-glucoside as the substrate (normal: 1.3 +/- 0.12 x 10(-13) mol/h/cell). The microassay was linear with time up to 4 h, for up to 20 mononucleate cells, and for individual multinucleate cells containing up to 12 nuclei. Complementation was examined in 11 fibroblasts strains fused in all pairwise combinations. In no instance was there any clear indication of complementation (at least 10-15% of normal activity to adequately account for experimental variation) although there was an indication of marginal increases in some fusions. On the other hand, the expected 50% activity was obtained in "heterozygous" fusions (normal/mutant) for both types of clinical variants. Our results are consistent with a single gene, presumably the structural gene encoding the enzyme, responsible for at least the infantile and adult variants, and confirm the autosomal recessive nature of the disorder.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6418635     DOI: 10.1007/BF00286645

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  15 in total

1.  Genetic complementation of propionyl-CoA carboxylase deficiency in cultured human fibroblasts.

Authors:  R A Gravel; K F Lam; K J Scully; Y Hsia
Journal:  Am J Hum Genet       Date:  1977-07       Impact factor: 11.025

2.  Quantitative assays of enzyme activity in single cells: early prenatal diagnosis of genetic disorders.

Authors:  P Hösli
Journal:  Clin Chem       Date:  1977-08       Impact factor: 8.327

3.  Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease.

Authors:  S P Peters; C J Coffee; R H Glew; R E Lee; D A Wenger; S C Li; Y T Li
Journal:  Arch Biochem Biophys       Date:  1977-09       Impact factor: 4.013

4.  Analysis of genetic complementation by whole-cell microtechniques in fibroblast heterokaryons.

Authors:  R A Gravel; A Leung; M Saunders; P Hösli
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

5.  Isolation and characterization of glucocerebrosidase from human placental tissue.

Authors:  P G Pentchev; R O Brady; S R Hibbert; A E Gal; D Shapiro
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

6.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  Properties of beta-glucosidase in cultured skin fibroblasts from controls and patients with Gaucher disease.

Authors:  B M Turner; K Hirschhorn
Journal:  Am J Hum Genet       Date:  1978-07       Impact factor: 11.025

8.  Infantile sialidosis: a phenocopy of type 1 GM1 gangliosidosis distinguished by genetic complementation and urinary oligosaccharides.

Authors:  R A Gravel; J A Lowden; J W Callahan; L S Wolfe; N M Ng Yin Kin
Journal:  Am J Hum Genet       Date:  1979-11       Impact factor: 11.025

9.  Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

Authors:  E I Ginns; R O Brady; S Pirruccello; C Moore; S Sorrell; F S Furbish; G J Murray; J Tager; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Assignment of the gene for acid beta-glucosidase to human chromosome 1.

Authors:  B Shafit-Zagardo; E A Devine; M Smith; F Arredondo-Vega; R J Desnick
Journal:  Am J Hum Genet       Date:  1981-07       Impact factor: 11.025

View more
  9 in total

1.  Lack of complementation in somatic cell hybrids between fibroblasts from patients with different forms of cystinosis.

Authors:  O L Pellett; M L Smith; A A Greene; J A Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

2.  Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

Authors:  S Tsuji; B M Martin; J A Barranger; B K Stubblefield; M E LaMarca; E I Ginns
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.

Authors:  E I Ginns; P V Choudary; S Tsuji; B Martin; B Stubblefield; J Sawyer; J Hozier; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

4.  Hunter disease (mucopolysaccharidosis type II) associated with unbalanced inactivation of the X chromosomes in a karyotypically normal girl.

Authors:  J T Clarke; W L Greer; P M Strasberg; R D Pearce; M A Skomorowski; P N Ray
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

5.  Glucocerebrosidase "processing" and gene expression in various forms of Gaucher disease.

Authors:  E Beutler; W Kuhl; J Sorge
Journal:  Am J Hum Genet       Date:  1985-11       Impact factor: 11.025

6.  Bloom syndrome: a single complementation group defines patients of diverse ethnic origin.

Authors:  R Weksberg; C Smith; L Anson-Cartwright; K Maloney
Journal:  Am J Hum Genet       Date:  1988-06       Impact factor: 11.025

7.  Glucocerebrosidase processing in normal fibroblasts and in fibroblasts from patients with type I, type II, and type III Gaucher disease.

Authors:  E Beutler; W Kuhl
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

8.  Posttranslational processing of human lysosomal acid beta-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts.

Authors:  J E Bergmann; G A Grabowski
Journal:  Am J Hum Genet       Date:  1989-05       Impact factor: 11.025

9.  Cross-reacting material in Gaucher disease fibroblasts.

Authors:  E Beutler; W Kuhl; J Sorge
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.